Sun Life Financial Inc Nektar Therapeutics Transaction History

Sun Life Financial Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 10, 2020	SELL	$15.87 - $23.12 $2,285 - $3,329	-144 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$16.91 - $36.27 $33 - $72	2 Added 1.41%	144 $3,000
Q2 2019 Aug 08, 2019	SELL	$31.0 - $36.3 $4,743 - $5,553	-153 Reduced 51.86%	142 $5,000
Q1 2019 May 14, 2019	SELL	$31.58 - $46.35 $5,779 - $8,482	-183 Reduced 38.28%	295 $10,000
Q4 2018 Feb 06, 2019	BUY	$30.43 - $56.65 $213 - $396	7 Added 1.49%	478 $16,000

Q3 2018 Nov 13, 2018	BUY	$46.46 - $68.49 $1,672 - $2,465	36 Added 8.28%	471 $29,000
Q2 2018 Aug 09, 2018	BUY	$46.25 - $104.45 $16,511 - $37,288	357 Added 457.69%	435 $21,000
Q1 2018 May 14, 2018	BUY	$57.4 - $108.44 $4,477 - $8,458	78 New	78 $0

128

111M

150K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $219M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Sun Life Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Sun Life Financial Inc with notifications on news.